AACR.org|

Thanks to a matching gift from a generous donor, your gift
will make twice the impact on cancer research until Dec. 31!

Learn about innovations in fundamental science and clinical
research that are advancing cancer prevention and treatments.

Read the American Association for Cancer Research’s 2019
report on research-driven progress against cancer.

Entrectinib is the second therapeutic of its kind approved
for use based on tumor biomarker rather than origination site.

Cancer research saves and transforms the lives of real people.
Read about their journeys from diagnosis to survivorship.

We've distributed more than $316 million
in cancer research funding since 2001

Our Research

We support all forms of research from basic and translational to clinical and population science on the more than 200 types of cancer.

Our People

The AACR's membership – more than 44,000 strong – features the world's leading cancer researchers and includes 44 Nobel laureates.

Our Impact

Our members have been at the forefront of every major advance in cancer research for the last 110+ years.

Donate

Make an Impact: Give to the AACR Foundation, where 88 cents of every dollar we raise supports innovative cancer research.

Donate

Volunteer

Use Your Talents: Help to raise money for cancer research by participating in our events or by creating an event of your own.

Volunteer

Take Action

Raise Your Hand: Get involved with the AACR's efforts to support, advocate for, and communicate the importance of cancer research.

Take Action

Thanks to a matching gift from a generous donor, your gift
will make twice the impact on cancer research until Dec. 31!

Learn about innovations in fundamental science and clinical
research that are advancing cancer prevention and treatments.

Read the American Association for Cancer Research’s 2019
report on research-driven progress against cancer.

Entrectinib is the second therapeutic of its kind approved
for use based on tumor biomarker rather than origination site.

Cancer research saves and transforms the lives of real people.
Read about their journeys from diagnosis to survivorship.

We've distributed more than $316 million
in cancer research funding since 2001

Our Research

Our People

Our Impact

Donate

Volunteer

Take Action

Cancer Connections

Tell Your Cancer Story

It's Lung Cancer Awareness Month

Cancer Today: Practical Knowledge. Real Hope.

It's Gastric Cancer Awareness Month

Cancer Research Catalyst

Pancreatic Cancer Awareness Month

It's Carcinoid Cancer Awareness Month

Cancer Survivor Journeys

Air Pollution May be Associated With Many Kinds of Cancer

Thanks to a matching gift from a generous donor, your gift will make twice the impact on cancer research until Dec. 31!

Learn about innovations in fundamental science and clinical research that are advancing cancer prevention and treatments.

Read the American Association for Cancer Research’s 2019 report on research-driven progress against cancer.

Entrectinib is the second therapeutic of its kind approved for use based on tumor biomarker rather than origination site.

Cancer research saves and transforms the lives of real people. Read about their journeys from diagnosis to survivorship.

We've distributed more than $316 million in cancer research funding since 2001

Our Research

Our People

Our Impact

Donate

Volunteer

Take Action

Cancer Connections

Thanks to a matching gift from a generous donor, your gift
will make twice the impact on cancer research until Dec. 31!

Learn about innovations in fundamental science and clinical
research that are advancing cancer prevention and treatments.

Read the American Association for Cancer Research’s 2019
report on research-driven progress against cancer.

Entrectinib is the second therapeutic of its kind approved
for use based on tumor biomarker rather than origination site.

Cancer research saves and transforms the lives of real people.
Read about their journeys from diagnosis to survivorship.

We've distributed more than $316 million
in cancer research funding since 2001